Jasper Therapeutics, Inc.
JSPR
$0.72
$0.022.35%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.77M | -55.73M | -75.80M | -91.02M | -90.92M |
| Total Depreciation and Amortization | 561.00K | 798.00K | 1.06M | 1.01M | 1.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.03M | -8.53M | 2.51M | 7.93M | 8.36M |
| Change in Net Operating Assets | -13.09M | -5.40M | -4.92M | 5.65M | 7.76M |
| Cash from Operations | -60.33M | -68.87M | -77.16M | -76.43M | -73.48M |
| Capital Expenditure | 0.00 | -7.00K | -7.00K | -103.00K | -377.00K |
| Sale of Property, Plant, and Equipment | 80.00K | 8.00K | 12.00K | 32.00K | 32.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 80.00K | 1.00K | 5.00K | -71.00K | -345.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.40M | 34.55M | 34.55M | 34.90M | 6.52M |
| Repurchase of Common Stock | -340.00K | -340.00K | -340.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 28.06M | 34.21M | 34.21M | 34.90M | 6.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.20M | -34.66M | -42.95M | -41.60M | -67.31M |